Axonopathy is associated with complex axonal transport defects in a model of multiple sclerosis

Brain Pathology

Volumn 22, Issue 4, 2012, Pages 454-471

  Kreutzer, Mihaela ^a,b   Seehusen, Frauke ^a   Kreutzer, Robert ^a,b   Pringproa, Kidsadagorn ^a,b   Kummerfeld, Maren ^a   Claus, Peter ^b,c   Deschl, Ulrich ^d   Kalkul, Arno ^d   Beineke, Andreas ^a   Baumgärtner, Wolfgang ^a,b   Ulrich, Reiner ^a,b  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Axonopathy; Multiple sclerosis; TMEV; Transport defects

Indexed keywords

BETA TUBULIN; KINESIN 5; TAU PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MICROARRAY ANALYSIS; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NERVE FIBER TRANSPORT; NEUROFILAMENT; NEUROPATHY; NONHUMAN; PROTEIN METABOLISM;

ANIMALS; AXONAL TRANSPORT; CARDIOVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; MICE; MICROARRAY ANALYSIS; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NEUROFILAMENT PROTEINS; SPINAL CORD; THEILOVIRUS;

EID: 84862488270     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2011.00541.x     Document Type: Article

References (62)

1. Ahmad FJ, Echeverri CJ, Vallee RB, Baas PW (1998) Cytoplasmic dynein and dynactin are required for the transport of microtubules into the axon. J Cell Biol 140:391-401. (Pubitemid 28078402)
2. Alano CC, Garnier P, Ying W, Higashi Y, Kauppinen TM, Swanson RA (2010) NAD+ depletion is necessary and sufficient for poly(ADP-ribose) polymerase-1-mediated neuronal death. J Neurosci 30:2967-2978.
3. Araki T, Sasaki Y, Milbrandt J (2004) Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305:1010-1013. (Pubitemid 39071777)
4. Bajaj NP, al-Sarraj ST, Leigh PN, Anderson V, Miller CC (1999) Cyclin dependent kinase-5 (CDK-5) phosphorylates neurofilament heavy (NF-H) chain to generate epitopes for antibodies that label neurofilament accumulations in amyotrophic lateral sclerosis (ALS) and is present in affected motor neurones in ALS. Prog Neuropsychopharmacol Biol Psychiatry 23:833-850. (Pubitemid 29416758)
5. Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19:185-193. (Pubitemid 36181903)
6. Coleman M (2005) Axon degeneration mechanisms: commonality amid diversity. Nat Rev Neurosci 6:889-898.
7. Collard JF, Cote F, Julien JP (1995) Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature 375:61-64.
8. Conforti L, Adalbert R, Coleman MP (2007) Neuronal death: where does the end begin? Trends Neurosci 30:159-166. (Pubitemid 46505033)
9. Czasch S, Paul S, BaumgartnerW(2006) A comparison of immunohistochemical and silver staining methods for the detection of diffuse plaques in the aged canine brain. Neurobiol Aging 27:293-305. (Pubitemid 43038554)
10. Deb C, Lafrance-Corey RG, Zoecklein L, Papke L, Rodriguez M, Howe CL (2009) Demyelinated axons and motor function are protected by genetic deletion of perforin in a mouse model of multiple sclerosis. J Neuropathol Exp Neurol 68:1037-1048.
11. Deb C, Lafrance-Corey RG, Schmalstieg WF, Sauer BM, Wang H, German CL et al (2010) CD8+ T cells cause disability and axon loss in a mouse model of multiple sclerosis. PLoS ONE 5:e12478.
12. Dziedzic T, Metz I, Dallenga T, Konig FB, Muller S, Stadelmann C, Bruck W (2010) Wallerian degeneration: a major component of early axonal pathology in multiple sclerosis. Brain Pathol 20:976-985.
13. Ferguson B, Matyszak MK, Esiri MM, Perry VH (1997) Axonal damage in acute multiple sclerosis lesions. Brain 120(Pt 3):393-399. (Pubitemid 27153632)
14. Gehrmann J, Banati RB, Cuzner ML, Kreutzberg GW, Newcombe J (1995) Amyloid precursor protein (APP) expression in multiple sclerosis lesions. Glia 15:141-151.
15. Gentleman SM, Nash MJ, Sweeting CJ, Graham DI, Roberts GW (1993) Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury. Neurosci Lett 160:139-144. (Pubitemid 23294725)
16. Gilley J, Coleman MP (2010) Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons. PLoS Biol 8:e1000300.
17. Gotow T (2000) Neurofilaments in health and disease. Med Electron Microsc 33:173-199.
18. Haist VUR, Kalkuhl A, Deschl U, Baumgärtner W (2011) Mild transcriptional changes of extracellular matrix but extensive matrix accumulation in a distinct spatio-temporal pattern within chronic demyelinated spinal cord lesions in Theiler's murine encephalomyelitis. Brain Pathol doi:10.1111/j.1750-3639.2011.00518.x.
19. Howe CL, Ure D, Adelson JD, LaFrance-Corey R, Johnson A, Rodriguez M (2007) CD8+ T cells directed against a viral peptide contribute to loss of motor function by disrupting axonal transport in a viral model of fulminant demyelination. J Neuroimmunol 188:13-21. (Pubitemid 47095011)
20. Kamal A, Almenar-Queralt A, LeBlanc JF, Roberts EA, Goldstein LS (2001) Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature 414:643-648. (Pubitemid 33151260)
21. Knowles HJ, te Poele RH, Workman P, Harris AL (2006) Niacin induces PPARgamma expression and transcriptional activation in macrophages via HM74 and HM74a-mediated induction of prostaglandin synthesis pathways. Biochem Pharmacol 71:646-656. (Pubitemid 43121998)
22. Kreutzer R, Kreutzer M, Propsting MJ, Sewell AC, Leeb T, Naim HY, Baumgartner W (2008) Insights into post-translational processing of beta-galactosidase in an animal model resembling late infantile human G-gangliosidosis. J Cell Mol Med 12:1661-1671.
23. Kummerfeld M, Meens J, Haas L, Baumgartner W, Beineke A (2009) Generation and characterization of a polyclonal antibody for the detection of Theiler's murine encephalomyelitis virus by light and electron microscopy. JVirol Methods 160:185-188.
24. Lee VM, Carden MJ, Schlaepfer WW, Trojanowski JQ (1987) Monoclonal antibodies distinguish several differentially phosphorylated states of the two largest rat neurofilament subunits (NF-H and NF-M) and demonstrate their existence in the normal nervous system of adult rats. J Neurosci 7:3474-3488. (Pubitemid 18000675)
25. Lew J, Winkfein RJ, Paudel HK, Wang JH (1992) Brain proline-directed protein kinase is a neurofilament kinase which displays high sequence homology to p34cdc2. J Biol Chem 267:25922-25926. (Pubitemid 23013996)
26. Lindquist S, Hassinger S, Lindquist JA, Sailer M (2011) The balance of pro-inflammatory and trophic factors in multiple sclerosis patients: effects of acute relapse and immunomodulatory treatment. Mult Scler 17:851-866.
27. Mancardi G, Hart B, Roccatagliata L, Brok H, Giunti D, Bontrop R et al (2001) Demyelination and axonal damage in a non-human primate model of multiple sclerosis. J Neurol Sci 184:41-49. (Pubitemid 32166724)
28. Masaki R, Saito T, Yamada K, Ohtani-Kaneko R (2000) Accumulation of phosphorylated neurofilaments and increase in apoptosis-specific protein and phosphorylated c-Jun induced by proteasome inhibitors. J Neurosci Res 62:75-83.
29. McGavern DB, Murray PD, Rodriguez M (1999) Quantitation of spinal cord demyelination, remyelination, atrophy, and axonal loss in a model of progressive neurologic injury. J Neurosci Res 58:492-504. (Pubitemid 29530433)
30. Miller BR, Press C, Daniels RW, Sasaki Y, Milbrandt J, DiAntonio A (2009) A dual leucine kinase-dependent axon self-destruction program promotesWallerian degeneration. Nat Neurosci 12:387-389.
31. Motil J, Chan WK, Dubey M, Chaudhury P, Pimenta A, Chylinski TM et al (2006) Dynein mediates retrograde neurofilament transport within axons and anterograde delivery of NFs from perikarya into axons: regulation by multiple phosphorylation events. Cell Motil Cytoskeleton 63:266-286.
32. Murray PD, Pavelko KD, Leibowitz J, Lin X, Rodriguez M (1998) CD4(+) and CD8(+) T cells make discrete contributions to demyelination and neurologic disease in a viral model of multiple sclerosis. JVirol 72:7320-7329. (Pubitemid 28377863)
33. Nikolaev A, McLaughlin T, O'Leary DD, Tessier-Lavigne M (2009) APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 457:981-989.
34. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938-952.
35. Penberthy WT, Tsunoda I (2009) The importance of NAD in multiple sclerosis. Curr Pharm Des 15:64-99.
36. Perrot R, Berges R, Bocquet A, Eyer J (2008) Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration. Mol Neurobiol 38:27-65.
37. Pringproa K, Rohn K, Kummerfeld M, Wewetzer K, Baumgartner W (2010) Theiler's murine encephalomyelitis virus preferentially infects immature stages of the murine oligodendrocyte precursor cell line BO-1 and blocks oligodendrocytic differentiation in vitro. Brain Res 1327:24-37.
38. Qian W, Shi J, Yin X, Iqbal K, Grundke-Iqbal I, Gong CX, Liu F (2010) PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta. J Alzheimers Dis 19:1221-1229.
39. Roussarie JP, Ruffie C, Brahic M (2007) The role of myelin in Theiler's virus persistence in the central nervous system. PLoS Pathog 3:e23.
40. Sato F, Omura S, Martinez NE, Tsunoda I (2011) Animal model for multiple sclerosis. In: Neuroinflammation, A Minagar (ed.), pp. 55-79. Elsevier Books: Burlington, MA.
41. Schirmer L, Antel JP, Bruck W, Stadelmann C (2011) Axonal loss and neurofilament phosphorylation changes accompany lesion development and clinical progression in multiple sclerosis. Brain Pathol 21:428-440.
42. Schlaepfer WW, Zimmerman UJ (1985) Mechanisms underlying the neuronal response to ischemic injury. Calcium-activated proteolysis of neurofilaments. Prog Brain Res 63:185-196.
43. Seehusen F, Baumgartner W (2010) Axonal pathology and loss precede demyelination and accompany chronic lesions in a spontaneously occurring animal model of multiple sclerosis. Brain Pathol 20:551-559.
44. Selvaraj V, Soundarapandian MM, Chechneva O, Williams AJ, Sidorov MK, Soulika AM et al (2009) PARP-1 deficiency increases the severity of disease in a mouse model of multiple sclerosis. J Biol Chem 284:26070-26084.
45. Shah JV, Flanagan LA, Janmey PA, Leterrier JF (2000) Bidirectional translocation of neurofilaments along microtubules mediated in part by dynein/dynactin. Mol Biol Cell 11:3495-3508.
46. Shea TB, Chan WK (2008) Regulation of neurofilament dynamics by phosphorylation. Eur J Neurosci 27:1893-1901. (Pubitemid 351521484)
47. Sobottka B, Harrer MD, Ziegler U, Fischer K, Wiendl H, Hunig T et al (2009) Collateral bystander damage by myelin-directed CD8+ T cells causes axonal loss. Am J Pathol 175:1160-1166.
48. Soulika AM, Lee E, McCauley E, Miers L, Bannerman P, Pleasure D (2009) Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis. J Neurosci 29:14965-14979.
49. Strack S, Westphal RS, Colbran RJ, Ebner FF, Wadzinski BE (1997) Protein serine/threonine phosphatase 1 and 2A associate with and dephosphorylate neurofilaments. Brain Res Mol Brain Res 49: 15-28. (Pubitemid 27453110)
50. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278-285. (Pubitemid 28065253)
51. Tsunoda I (2008) Axonal degeneration as a self-destructive defense mechanism against neurotropic virus infection. FutureVirol 3:579-593.
52. Tsunoda I, Kuang LQ, Libbey JE, Fujinami RS (2003) Axonal injury heralds virus-induced demyelination. Am J Pathol 162:1259-1269. (Pubitemid 36350670)
53. Tsunoda I, Tanaka T, Saijoh Y, Fujinami RS (2007) Targeting inflammatory demyelinating lesions to sites of Wallerian degeneration. Am J Pathol 171:1563-1575. (Pubitemid 350158317)
54. Tsunoda I, Tanaka T, Terry EJ, Fujinami RS (2007) Contrasting roles for axonal degeneration in an autoimmune versus viral model of multiple sclerosis: when can axonal injury be beneficial? Am J Pathol 170:214-226. (Pubitemid 47339201)
55. Ulrich R, Seeliger F, Kreutzer M, Germann PG, Baumgartner W (2008) Limited remyelination in Theiler's murine encephalomyelitis due to insufficient oligodendroglial differentiation of nerve/glial antigen 2 (NG2)-positive putative oligodendroglial progenitor cells. Neuropathol Appl Neurobiol 34:603-620.
56. Ulrich R, Kalkuhl A, Deschl U, Baumgartner W (2010) Machine learning approach identifies new pathways associated with demyelination in a viral model of multiple sclerosis. J Cell Mol Med 14:434-448.
57. Ure D, Rodriguez M (2000) Extensive injury of descending neurons demonstrated by retrograde labeling in a virus-induced murine model of chronic inflammatory demyelination. J Neuropathol Exp Neurol 59:664-678. (Pubitemid 30626737)
58. Veeranna SKT, Link WT, Jaffe H, Wang J, Pant HC (1995) Neuronal cyclin-dependent kinase-5 phosphorylation sites in neurofilament protein (NF-H) are dephosphorylated by protein phosphatase 2A. J Neurochem 64:2681-2690.
59. Vohra BP, Sasaki Y, Miller BR, Chang J, DiAntonio A, Milbrandt J (2010) Amyloid precursor protein cleavage-dependent and -independent axonal degeneration programs share a common nicotinamide mononucleotide adenylyltransferase 1-sensitive pathway. J Neurosci 30:13729-13738.
60. Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW (1975) A protein factor essential for microtubule assembly. Proc Natl Acad Sci U SA 72:1858-1862.
61. Xia CH, Roberts EA, Her LS, Liu X, Williams DS, Cleveland DW, Goldstein LS (2003) Abnormal neurofilament transport caused by targeted disruption of neuronal kinesin heavy chain KIF5A. J Cell Biol 161:55-66. (Pubitemid 36459079)
62. Yabe JT, Pimenta A, Shea TB (1999) Kinesin-mediated transport of neurofilament protein oligomers in growing axons. J Cell Sci 112:3799-3814.